Hot Tech Stocks To Buy For 2014

Proxy fights are like the demolition derby of the investment world. Pitting management desperately trying to keep their jobs against passionate rich investors always makes for an entertaining fight. Unfortunately, even if management makes it to the finish line, it's likely to limp across, beaten up in the process.

The latest entertainment comes from VIVUS (NASDAQ: VVUS  ) and First Manhattan, owner of 9.9% of the biotech.

First Manhattan dealt a blow on Monday, laying out its case for how the company is "hemorrhaging cash," urging shareholders to vote for its slate of board members.

Source: First Manhattan.

VIVUS' management struck back Tuesday, refuting many of First Manhattan's claims in a step by step approach.

Lies, damn lies, and statistics
First Manhattan points to VIVUS' large short interest as a sign that investors aren't confident in the management team. Management counters, pointing out that its most direct competitor, Arena Pharmaceuticals (NASDAQ: ARNA  ) , has a comparable short interest. I'm not sure that's the best counter argument -- maybe investors hate Arena's management, too? -- but the point is that it's clear many investors are betting that companies continue to struggle to sell obesity drugs.

Top 5 Clean Energy Companies To Invest In 2015: Synchronoss Technologies Inc.(SNCR)

Synchronoss Technologies, Inc. provides on-demand transaction management solutions primarily in North America. It offers solutions to manage transactions, including device and service procurement, provisioning, activation, intelligent connectivity management, and content synchronization for communications service providers, cable operators/multi-services operators, original equipment manufacturers with embedded connectivity, and e-Tailers/retailers. The company provides ConvergenceNow, ConvergenceNow Plus+, and InterconnectNow platforms that provide on-demand order processing, transaction management, service provisioning, device activation, intelligent connectivity, and content transfer and synchronization through e-commerce, telesales, enterprise, indirect, and other retail outlet channels. It also offers PerformancePartner Portal, a graphical user interface that allows the entry of transaction data into the gateway; Gateway Manager, which offers the capability to fulfill multiple types of transactions; WorkFlow Manager that provides interaction with third-party relationships, as well as enables customers to have a single transaction view, including data from third-party systems; and Visibility Manager, which offers a centralized reporting platform for intelligent analytics around the workflow, transaction management information, historical trending, and mobile reporting for users to receive critical transaction data on mobile devices. In addition, the company provides Content Synchronization Portal that facilitates content migration across devices from different platforms; Device Client, which offers connectivity for activation, connection management, and content migration and synchronization for feature phones, smartphones, computers, and tablets. It sells its products and services through direct sales force and strategic partners. Synchronoss Technologies, Inc. was founded in 2000 and is headquartered in Bridgewater, New Jersey.

Advisors' Opinion:

• [By Lee Jackson]

  Synchronoss Technologies Inc. (NASDAQ: SNCR) may not only beat earnings, but CNBC�� Jim Cramer is touting it as a breakout stock that may be ready to explode for investors. The company provides software-based activation and personal cloud solutions for connected devices. The consensus price target for the stock is $38.

• [By Roberto Pedone]

  Synchronoss Technologies (SNCR) is a provider of on-demand transaction management solutions. This stock closed up 1% at $35.38 in Monday's trading session.

  Monday's Volume: 508,000
  
  Three-Month Average Volume: 284,678
  
  Volume % Change: 80%

  From a technical perspective, SNCR trended up modestly higher here right above some near-term support at $34.27 with above-average volume. This stock has been uptrending strong for the last month and change, with shares moving higher from its low of $26.60 to its recent high of $36.49. During that move, shares of SNCR have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of SNCR within range of triggering a near-term breakout trade. That trade will hit if SNCR manages to take out some near-term overhead resistance levels at $36 to its 52-week high at $36.49 with high volume.

  Traders should now look for long-biased trades in SNCR as long as it's trending above some support at $34 and then once it sustains a move or close above those breakout levels with volume that this near or above 284,678 shares. If that breakout hits soon, then SNCR will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $40 to $43.

Hot Tech Stocks To Buy For 2014: Multi-Fineline Electronix Inc.(MFLX)

Multi-Fineline Electronix, Inc. engages in the engineering, design, and manufacture of flexible printed circuit boards and related component assemblies for the electronics industry. The company offers integrated flexible printed circuits and component assembly solutions, such as design and application engineering, prototyping, high-volume fabrication, component assembly, and testing. It serves original equipment manufacturer and electronic manufacturing service providers in various sectors of the electronics industry, such as mobile phones and smart phones, tablets, consumer products, portable bar code scanners, computer/data storage, and medical devices. The company operates in the United States, China, Singapore, Malaysia, and the United Kingdom. Multi-Fineline Electronix, Inc. was founded in 1984 and is headquartered in Anaheim, California. Multi-Fineline Electronix, Inc. is a subsidiary of WBL Corporation Limited.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Multi-Fineline Electronix (Nasdaq: MFLX  ) , whose recent revenue and earnings are plotted below.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Multi-Fineline Electronix (Nasdaq: MFLX  ) , whose recent revenue and earnings are plotted below.

Hot Tech Stocks To Buy For 2014: OncoGenex Pharmaceuticals Inc.(OGXI)

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company?s clinical stage products include Custirsen, a phase III clinical stage product for treatment in men with metastatic castrate-resistant prostate cancer; OGX-427, which is in phase II clinical development stage is designed to inhibit heat shock protein 27; and SN2310 that completed phase I stage of clinical development is designed to evaluate safety in patients with advanced cancer. Its pre clinical stage products include GX-225 that is focused on reducing the production of IGFBP-2 and IGFBP-5; and CSP-9222, lead compound from a family of caspase activators. OncoGenex Pharmaceuticals, Inc. is based in Bothell, Washington.

Advisors' Opinion:

• [By John McCamant]

  2014 is shaping up to be the most important year for OncoGenex Pharmaceuticals (OGXI), and, we believe, it can very well represent a major inflection point for the company with positive Synergy results.

• [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Teva Pharmaceutical Industries Ltd.(TEVA) and OncoGenex Pharmaceuticals Inc.(OGXI) said their experimental drug for hard-to-treat cases of prostate cancer didn’t result in statistically significant improvement in overall survival in a Phase 3 study. OncoGenex shares dropped 48% to $5 premarket.

Hot Tech Stocks To Buy For 2014: Activision Blizzard Inc(ATVI)

Activision Blizzard, Inc., through its subsidiaries, publishes online, personal computer (PC), console, and handheld games worldwide. The company develops and publishes PC-based computer games and maintains its proprietary online-game related service, Battle.net. It publishes interactive software products and peripherals. Its products cover various game categories, such as action/adventure, action sports, racing, role-playing, simulation, first-person action, music, and strategy. Activision?s products comprise Monsters vs. Aliens, Guitar Hero, X-Men Origins, PROTOTYPE, Transformers, Ice Age, Wolfenstein, Marvel Ultimate Alliance, Bakugan Battle Brawlers, DJ Hero, Band Hero, Call of Duty, Tony Hawk, Guitar Hero, Three map packs for Call of Duty, True Crime, Spider-Man, Bakugan, Blur, and Singularity. Its customers include retail outlets and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores. Activision Blizzard, Inc. is based in Santa Monica, California. Activision Blizzard, Inc. operates as a subsidiary of Vivendi.

Advisors' Opinion:

• [By Demitrios Kalogeropoulos]

  And Activision Blizzard (NASDAQ: ATVI  ) can't be happy about it.

  That's because the success of the film should give a big jolt to the marketing campaign behind Disney's upcoming video game, Infinity, set to challenge Activision's Skylanders franchise later this summer. With Skylanders, Activision struck video game gold last year, carving out a new genre for children that features toys that players can collect and trade while also interacting with them inside a console game. It was worth more than $1 billion in sales through the end of last year.

• [By Chris Hill]

  Yum! Brands (NYSE: YUM  ) slips on a 29% drop in same-store sales in China. Nokia (NYSE: NOK  ) rises on an analyst upgrade. Monsanto (NYSE: MON  ) falls despite a favorable Supreme Court ruling. And Activision Blizzard (NASDAQ: ATVI  ) continues its post-earnings decline.